相关实验视频

Updated: May 3, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection

Published on: October 12, 2017

在重症监护中心的甲基蓝色

Praveen Reddy Elmati¹, Teja Nagaradona², Vikas Raghove³

¹Department of Anesthesiology, Saint Clair Hospital, Dover, NJ 07801, United States.

World journal of critical care medicine

|August 29, 2025

概括

甲蓝 (MB) 在重症监护室 (ICU) 治疗耐火性休克,特别是败血症和血管性休克方面具有前景. 需要进一步的研究来证实其长期安全性和在重症监护机构的最佳使用.

科学领域:

药理学和重症监护医学.

背景情况:

甲基蓝 (MB) 是一种多方面的化合物,具有作为染料,消毒剂和治疗甲基红蛋白血症的历史应用.
其已知的机制包括血管收缩,甲血球降低,瓜尼酸环酶抑制和抗炎性质.

研究的目的:

审查有关在重症监护室使用甲蓝 (MB) 的现有文献.
评估MB在处理各种形式的耐火冲击中的有效性和应用.

主要方法:

使用PubMed和谷歌学者进行了全面的文献搜索.
搜索词包括"甲基蓝", "重症监护", "重症监护", "败血症", "手术", "药物动力学"和"药物动力学".
分析了相关的英语文章.

主要成果:

甲蓝 (MB) 已在治疗耐火性休克患者,如败血症和血管性休克中表现出有用性.
它的应用扩展到手术患者和药物诱导的低血压病例.

结论:

甲蓝 (MB) 是治疗热血病和血管的有希望的选择.
进一步的随机对照试验至关重要,以确定长期的安全性,最佳时间,剂量和重症监护中MB的持续时间.

关键词:

关键的护理分布性冲击强化护理甲蓝色的消毒性休克血管性休克

更多相关视频

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury

Published on: October 18, 2024

相关概念视频

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: